The CD53 antigen is a tetraspanin protein of the lymphoid-myeloid lineage, but its implication in biological effects is hardly known. Radioresistant tumor cells express very high levels of this antigen. We have studied the effect of CD53 antigen ligation on the survival response of tumor cells to serum deprivation, a wellknown stimulator of cell death that may mimic the tumor environment; for this aim IR938F and Jurkat cells, a Band T-cell lymphoma, were used. Ligation of CD53 triggers a survival response and reduces the number of cells that enter apoptosis. In CD53-stimulated cells there is a significant reduction in caspase activation, measured by caspase processing of poly ADP-ribose polymerase, as well as a reduction in the fragmentation of DNA. CD53-stimulated cells also have an increase in the level of bcl-X L and a reduction of bax protein, two components of the mitochondrial apoptotic pathway, changing their ratio by 24-fold in the direction of survival. This survival signal appears to be mediated by activation of the AKT, as detected by its phosphorylation in Ser473 upon CD53 ligation. The CD53 antigen interactions might contribute to cell survival in poorly vascularized regions of the tumor mass.
The CD53 antigen is a tetraspanin protein of the lymphoid-myeloid lineage, but its implication in biological effects is hardly known. Radioresistant tumor cells express very high levels of this antigen. We have studied the effect of CD53 antigen ligation on the survival response of tumor cells to serum deprivation, a wellknown stimulator of cell death that may mimic the tumor environment; for this aim IR938F and Jurkat cells, a Band T-cell lymphoma, were used. Ligation of CD53 triggers a survival response and reduces the number of cells that enter apoptosis. In CD53-stimulated cells there is a significant reduction in caspase activation, measured by caspase processing of poly ADP-ribose polymerase, as well as a reduction in the fragmentation of DNA. CD53-stimulated cells also have an increase in the level of bcl-X L and a reduction of bax protein, two components of the mitochondrial apoptotic pathway, changing their ratio by 24-fold in the direction of survival. This survival signal appears to be mediated by activation of the AKT, as detected by its phosphorylation in Ser473 upon CD53 ligation. The CD53 antigen interactions might contribute to cell survival in poorly vascularized regions of the tumor mass. Oncogene (2003 Oncogene ( ) 22, 1219 Oncogene ( -1224 Oncogene ( . doi:10.1038 Keywords: CD53; tetraspanin antigen; apoptosis; AKT The tetraspanin proteins constitute a family of 26 membrane proteins with four hydrophobic transmembrane domains and two extracellular loops, which may account for their extracellular interactions and functional specificity. These proteins form complexes among themselves, of which the subunits are individual tetraspanin proteins. Some of the tetraspanin proteins are rather ubiquitous, such as CD9 or CD81, but others have a more restricted pattern of expression as CD37, CD53, peripherin and uroplakin (Berditchevski, 2001; Boucheix and Rubinstein, 2001; Hemler, 2001) . Tetraspanins have been detected both as free molecules, or interacting with different types of receptors, such as EGF-R, HB-EGF (Wang et al., 2002) or proteins with immunoglobulin domains, such as EWI-2 (Stipp et al., 2001) ; they also interact with MHC molecules and other membrane proteins, such as integrins, particularly those with the b1 subunit (Berditchevski, 2001; Boucheix and Rubinstein, 2001) . Tetraspanin proteins can influence several biological processes, such as cell motility (Higashiyama et al., 1995; Miyake et al., 1995) , and homotypic adhesion (Masellis-Smith et al., 1990; Lagaudriere-Gesbert et al., 1997; Lazo et al., 1997; Levy et al., 1998; Yanez-Mo et al., 1998; Shibagaki et al., 1999) . There is a general consensus that tetraspanin molecules modulate interaction with the extracellular environment, and recently the specific interaction of CD9 with fibronectin has been characterized (Longhurst et al., 2002) , but in general tetraspanin natural ligands are still unknown. Signaling by tetraspanin proteins have generally been attributed to their interactions with other membrane proteins, and as such characterized as costimulatory molecules. However, tetraspanin proteins have not yet been associated with the control of specific biological processes, although some reports show that some antigens modulate cell proliferation, cell adhesion and motility.
Tetraspanin antigens have been individually studied in many tumor types. In general, a reduction in antigen levels was correlated with poor prognosis (Radford et al., 1995) , such as is the case for CD9 in lung (Higashiyama et al., 1997) , breast (Huang et al., 1998) and esophagus carcinomas (Uchida et al., 1999) ; CD82 in prostate (Dong et al., 1995) , pancreatic (Guo et al., 1996) and breast cancer (Huang et al., 1998) ; or CD63 in melanoma (Radford et al., 1995) . The role of CD9 has been related to its modulation of cell motility, since the reintroduction of CD9 in the cell acts as a brake (Ikeyama et al., 1993) . In addition, CD53 deficiency has a clinical phenotype similar to those of inherited defects of cell adhesion molecules (Mollinedo et al., 1997) . Tumor cells express simultaneously several tetraspanin antigens that partially reflect a developmental stage, as shown in Burkitt lymphomas (Ferrer et al., 1998) . In other lymphomas, CD53 is overexpressed in germinal center and in follicular B-cell lymphomas (Alizadeh et al., 2000) . As a result of the complex tetraspanin pattern of gene expression, it is very likely that the adhesion and migration properties of tumors are conditioned by the alteration in the composition of cell-specific expression patterns (Sugiura and Berditchevski, 1999; Testa et al., 1999) .
In this report, we focused our attention on the CD53 antigen, a tetraspanin whose expression is mainly restricted to the lymphoid-myeloid lineage (Maecker et al., 1997) , and which is upregulated in radiationresistant cells (Voehringer et al., 2000) . Many cells, when they lose their extracellular matrix interactions or are placed under poor growth conditions, undergo apoptosis (Frisch and Ruoslahti, 1997; Frisch and Screaton, 2001) . In this work, we have studied the effect of CD53 antigen ligation as a surrogate mechanism for mimicking its interactions with the extracellular environment, which triggers a protective response against the apoptosis induced by serum deprivation.
First, the presence of the CD53 antigen in rat IR938F cells and human Jurkat cells was determined by flow cytometry (Figure 1 ). To study the effects of CD53 ligation on cell survival, we used the cell line IR938F, derived from a rat B-cell lymphoma, which expresses high levels of CD53 and in which several of its signaling components have already been characterized (Bosca´and Lazo, 1994; Barcia et al., 1996; Lazo et al., 1997) . These cells, at a density of 5 Â 10 5 cells per milliliter, were deprived of serum for 24 h before the addition of 10 mg of MRC OX44 specific for the rat CD53 antigen (Angelisova et al., 1990) . At different time points, the cells were analysed by flow cytometry to follow their progression through the cell cycle, or the induction of cell death as a result of the starvation. The result for IR938F cells is shown in Figure 2a . After 24 h in the presence of antibody, the number of cells in the apoptosis window is 9.82% (s.d. ¼ 4.53, n ¼ 5), while in the control nontreated cells the apoptotic population represents 25.6% (s.d. ¼ 5.53, n ¼ 5). The control cells clearly start to die after 24 h, while the cells in the presence of anti-CD53 progress through the cell cycle, with an increase in the S and G2/M populations. At later time points (72 h), the differences are still clearly noticeable despite the severe starvation conditions.
To demonstrate that the protective effect of CD53 ligation is not restricted to a cell type or antibody, a similar experiment was performed using a human cell line, Jurkat cells derived from a T-cell lymphoma, which expresses high levels of the CD53 antigen (Yunta et al., 2002) . After overnight serum deprivation of Jurkat cells, the monoclonal antibody MEM53, specific for human CD53, was added to the culture and its effect was analysed by flow cytometry. The result is shown in Figure 2b . At 24 h after the addition of MEM53 antibody, the apoptotic population represents 11.9% of the population, while in the control cells it is 21.5%. Therefore, it was concluded that ligation of the CD53 antigen induces a high protection of the apoptosis occurring in different cells as a consequence of serum deprivation.
If CD53 ligation promotes cell survival, it is likely that it will also reduce the level of activation of the execution mechanism of apoptosis triggered by the serum deprivation response. The execution of the apoptotic process is mediated by the activation of caspases (Igney and Krammer, 2002; Shi, 2002) . Activated caspase-3 degrades poly ADP-ribose polymerase (PARP) and generates, in addition to the intact protein of 113 kDa, a shorter proteolytic fragment of 89 kDa. As shown in Figure 3a , at the same time points, more noticeably at 12 and 24 h, the band of 85 kDa is clearly detected in the untreated control cells, but not in the MRC OX44-treated cells. A similar effect was observed in Jurkat cells in the presence of MEM53 (not shown). Also, the ligation of CD53 reduces the fragmentation of total DNA in response to starvation, as shown for IR938F cells (Figure 3b ). These observations confirm that the ligation of the CD53 antibody is protecting the cells from the activation of apoptosis as a response to serum deprivation.
It is likely that if CD53 ligation induces apoptosis protection, molecules that regulate apoptosis will modify their levels in the direction of a protective effect. The bcl-X L and bax proteins have opposite effects on apoptosis; while bcl-X L has a protective effect (Boise et al., 1993) , bax is a promoter of cell death (Miyashita et al., 1994) . Therefore, the levels of both proteins were monitored in starved IR938F cells in the presence of MRC OX44 or in controls. As shown in Figure 4 , following the ligation of the CD53 antigen there is an Overall, these variations in protein levels represent a 24-fold change in the bcl-X L /bax ratio in favor of a protective reaction in the presence of MRC OX44. These apoptosis protective changes are already noticeable at 9-12 h poststimulation. All these observations are consistent with the generation of a signal in CD53 that triggers a protective response against the apoptosis induced by serum deprivation that implicates the mitochondrial pathway (Igney and Krammer, 2002; Shi, 2002) . One of the main cellular survival pathways is mediated by the activation of the PI3kinase-AKT pathway (Gottlieb et al., 2002) . AKT is activated by phosphorylation in Thr308 and Ser473 (Scheid and Woodgett, 2001 ). Several studies have previously shown that phosphoinositol kinases are activated as part of the response to CD53 ligation (Bosca´and Lazo, 1994; Zhang et al., 2001) , and the effects induced by OX44 were sensitive to inhibitors of PI3kinase . Therefore, it is very likely that the survival signal generated by CD53 ligation might implicate the AKT pathway. To test this possibility, the phosphorylation of AKT in Ser473 as part of the response to CD53 ligation was determined. Rat IR938F cells were treated with the MRC OX44 antibody and the phosphorylation of AKT was determined at different time points. As shown in Figure 5 , there is a peak of AKT phosphorylation in Ser473 10 min after addition of the MEM53 antibody, suggesting that this might be a component of the survival signal initiated by CD53 antigen ligation. A similar effect was also induced in Jurkat cells.
The signaling pathways implicated in apoptosis protection are complex. In IR938F cells and in Jurkat cells, in addition to the phosphorylation of AKT detected in this report, other pathways implicated in proliferation and apoptosis are also activated. The signaling pathways activated by CD53 antigen ligation to initiate a survival response are likely to be . The cells were analysed by flow cytometry at specific time points after antibody addition, OX44 or MEM53. The reduction in the apoptosis window (M1) is clearly detectable at 24 h, as indicated by the arrow in both cell types. M2 represents the G0/C1 cell cycle phase, M3 represents the S phase, and M4 represents the G2/M cell cycle population. The DNA contents in different cell populations were determined by ethidium bromide staining in a FACScalibur flow cytometer (Becton-Dickinson). The rat B-cell immunocytoma IR938F was grown in DMEM supplemented with 10% fetal calf serum. The human Jurkat cell line, from a T-cell lymphoma, was grown in DMEM supplemented with 10% fetal calf serum. The cells were grown at 371C with 5% CO 2 and 98% humidity very complex, and not just mediated by a unique pathway. It is known that CD53 ligation activates phospholipase C and protein kinase C (Bosca´and Lazo, 1994; Barcia et al., 1996; Lazo et al., 1997) ; the latter even physically interacts with tetraspanin antigens after its translocation to the membrane (Zhang et al., 2001) . Also, there is a transient activation of the N-terminal Jun kinase (JNK) after CD53 ligation (Yunta et al., 2002) . All these pathways, protein kinase C (Musashi et al., 2000; Herr and Debatin, 2001) , JNK (Herr and Debatin, 2001 ) and AKT (Kennedy et al., 1997) have been associated with apoptosis protection. In IR938F cells, the ligation of CD53 also induced homotypic adhesion ; a similar effect on adhesion is induced in human Jurkat cells, which is more noticeable after 24 h ( Figure 6 ). As a result of the timing implicated in the two effects, apoptosis protection and adhesion, both are likely to be a consequence of the simultaneous activation of several signaling pathways initiated in CD53.
In this report, it is shown that ligation of the rat CD53 antigen clearly protects from the apoptotic response that is initiated as a result of serum deprivation.
There is some evidence where the presence of CD53 antigen has been correlated with cell survival. First, the Assay of proteolytic processing of PARP by caspase activation. IR928F cells, after serum deprivation for 12 h, were incubated in the presence of a control or of the MRC OX44 antibody, specific for the rat CD53 antigen. The complete PARP protein has 113 kDa, and the caspase processed PARP fragment has 89 kDa. The PARP protein was detected with a monoclonal antibody from Enzyme Systems Products (Livermore, CA, USA) at a 1 : 5000 dilution for Western blots. The antibody against the PCNA antigen was obtained from Transduction Laboratories and used at a 1 : 5000 dilution for western blots. The control for loading was bactin, which was detected with the AC-15 antibody from Sigma (St Louis, MO, USA) and used at a 1 : 5000 dilution. The products were analysed by SDS-PAGE under denaturing conditions and transferred to Immobilon-P membranes (Millipore, Bedford, MA, USA). The membranes were blocked with 5% skimmed milk in PBS, and then incubated with the specific antibody, followed by a rabbit anti-mouse IgG with peroxidase and developed with an ECL chemiluminescence kit from Amersham. The films were digitized at high resolution in a UMAX scanner. Quantification was performed using either the PCBas program from Fujibas phosphorimager (Fuji, Japan) or a Personal Imager from Bio-Rad (Hercules, CA, USA). The total DNA (10 mg) was analysed in a 1% agarose gel in TAE with 1 kb size marker (Invitrogen, Carlsbad, CA, USA) Figure 4 Effect of CD53 ligation by MRC OX44 in the level of bcl-X L and bax in IR938F cells. The time after antibody addition is indicated. Each gel lane was loaded with 100 mg of whole cell extract. The blot was developed with a specific antibody for either bcl-X L or bax proteins. The gel loading was determined by the detection of b-actin that was used for the normalization of bands in the quantification of the digitized blots. The specific antibodies for bcl-X L (clone 2H12) and for bax (clone 6A7) were from BDPharmingen (San Diego, CA, USA). The blot was developed with an ECL chemiluminescence kit from Amersham , and the total AKT protein was detected with a polyclonal anti-AKT antibody from Santa Cruz (Santa Cruz, CA, USA). The gel was loaded with 100 mg of whole cell extract presence of CD53 is implicated in thymic selection; CD53-expressing cells are those that survive and mature (Puls et al., 2002) . Second, the rescue of monocytes induced by GM-CSF, mediated by the transcription factor PU.1, is accompanied by an increase in the expression of CD53 (Henkel et al., 2002) . Interestingly, PU.1 is one of the main regulatory factors of the CD53 gene (Herna´ndez-Torres et al., 2001) . Finally, there are some highly specialized members of the tetraspanin family, such as the RDS/peripherin protein in the retina (Travis et al., 1991) , where mutations result in the apoptotic degeneration of retinal cells and subsequent blindness (van Soest et al., 1999) . Also, CD53 reflects a phenotype of resistance to radiation, as has been demonstrated by the overexpression of CD53 (Voehringer et al., 2000) .
In conclusion, the observations made in this report suggest that CD53 antigen stimulation might, under some circumstances, have a protective role against programmed cell death that might partly explain a role for CD53 when the antigen is overexpressed in tumors.
